Hereditary erythrocytosis in the Chuvash Republic. À literature review
https://doi.org/10.21682/2311-1267-2024-11-2-74-84
Abstract
The purpose of this review is to update information about the epidemiology, clinical-pathogenetic and genetic characteristics, and therapeutic approach to familial inherited erythrocytosis (FIE) in children in the Chuvash Republic.
This review presents updated data indicating that the variant of congenital polycythemia with the VHLR200W (598C>T) mutation in the Chuvash Republic does not have the expected association with tumor predisposition syndrome induced by VHL and does not lead to an increased frequency of their occurrence. Thrombosis largely explains the morbidity and mortality from congenital erythrocytosis, but patients with the Chuvash mutation show a reduced body mass index, systolic blood pressure levels, glucose and HbA1c levels, and leukocyte and platelet counts compared to control groups. A higher hematocrit level is not an independent predictor of thrombotic risk in children and adults. Moreover, prospective randomized studies have demonstrated that phlebotomy, performed to reduce hematocrit levels, is associated with a higher thrombotic risk.
Supporting agencies: The study was performed without external funding.
About the Authors
I. I. Sergeev
Chuvash State University named after I.N. Ulyanov
Russian Federation
Russian Federation
Assistant at the Department of Pediatrics and Pediatric Surgery
428015, Chuvash Republic, Cheboksary, Moskovsky Prosp., 15
K. D. Burtsev
Chuvash State University named after I.N. Ulyanov
Russian Federation
Russian Federation
Assistant at the Department of Traumatology, Orthopedics and Emergency Medicine
428015, Chuvash Republic, Cheboksary, Moskovsky Prosp., 15
N. S. Smetanina
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Russian Federation
Dr. of Sci. (Med.), Professor, Deputy Director General – Director of Regional Scientific and Analytical Work
1 Samory Mashela St., Moscow, 117997
References
1. Gordeuk V.R., Stockton D.W., Prchal J.T. Congenital polycythemias/ erythrocytoses. Haematologica. 2005;90(1):109–16. PMID: 15642677.
2. Lenglet M., Robriquet F., Schwarz K., Camps C., Couturier A., Hoogewijs D., Buff et A., Knight S.J.L., Gad S., Couvé S., Chesnel F., Pacault M., Lindenbaum P., Job S., Dumont S., Besnard T., Cornec M., Dreau H., Pentony M., Kvikstad E., Deveaux S., Burnichon N., Ferlicot S., Vilaine M., Mazzella J-M., Airaud F., Garrec C., Heidet L., Irtan S., Mantadakis E., Bouchireb K., Debatin K-M., Redon R., Bezieau S., Bressac-de Paillerets B., Teh B.T., Girodon F., Randi M-L., Putti M.C., Bours V., Van Wijk R., Göthert J.R., Kattamis A., Janin N., Bento C., Taylor J.C., Arlot-Bonnemains Y., Richard S., Gimenez-Roqueplo A-P., Cario H., Gardie B. Identifi cation of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel–Lindau disease. Blood. 2018;132(5):469–83. doi: 10.1182/blood-2018-03-838235.
3. Ang S.O., Chen H., Hirota K., Gordeuk V.R., Jelinek J., Guan Y., Liu E., Sergueeva A.I., Miasnikova G.Y., Mole D., Maxwell P.H., Stockton D.W., Semenza G.L., Prchal J.T. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet. 2002;32(4):614–21. doi: 10.1038/ng1019.
4. Krasnov M.V., Pavlova G.P., Wasserman N.N., Krasnov V.M., Smetanina N.S., Tokarev Yu.N. Ethno-territorial, genetic features of familial hereditary erythrocytosis in children of the Chuvash Republic. Prakticheskaya meditsina = Practical Medicine. 2008;7(31):69–73. (In Russ.)
5. Sergeyeva A., Gordeuk V.R., Tokarev Y.N., Sokol L., Prchal J.F., Prchal J.T. Congenital Polycythemia in Chuvashia. Blood. 1997;89(6):2148–54. PMID: 9058738.
6. Ang S.O., Chen H., Gordeuk V.R., Sergueeva A.I., Polyakova L.A., Miasnikova G.Y., Kralovics R., Stockton D.W., Prchal J.T. Endemic Polycythemia in Russia: Mutation in the VHL Gene. Blood Cells Mol Dis. 2002;28(1):57–62. doi: 10.1006/bcmd.2002.0488.
7. Dmitrieva M.G., Gazenko L.O., Polyakova L.A., Efi mova N.K., Krekhnov B.V., Tokarev Yu.N. Violation of the process of oxygen utilization by tissues in hereditary erythrocytosis. Doklady akademii nauk SSSR = Reports of the USSR Academy of Sciences. 1977;286(5). (In Russ.)
8. Tomasic N.L., Piterkova L., Huff C., Bilic E., Yoon D., Miasnikova G.Y., Sergueeva A.I., Niu X., Nekhai S., Gordeuk V., Prchal J.T. The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is diff erent from that of Chuvash polycythemia (VHL 598C>T:R200W). Haematologica. 2013;98(4):560–7. doi: 10.3324/haematol.2012.070508.
9. Perrotta S., Nobili B., Ferraro M., Migliaccio C., Borriello A., Cucciolla V., Martinelli V., Rossi F., Punzo F., Cirillo P., Parisi G., Zappia V., Rotoli B., Ragione F.D. Von Hippel–Lindau-dependent polycythemia is endemic on the island of Ischia: identifi cation of a novel cluster. Blood. 2006;107(2):514–9. doi: 10.1182/blood-2005-06-2422.
10. Mallik N., Sharma P., Hira J.K., Chhabra S., Sreedharanunni S., Kumar N., Naseem S., Updesh M., Sachdeva S., Ahluwalia J., Malhotra P., Varma N., Varma S., Das R. Genetic basis of unexplained erythrocytosis in Indian patients. Eur J Haematol. 2019;103:124–30. doi: 10.1111/ejh.13267.11.
11. Sergueeva A., Miasnikova G., Shah B.N., Song J., Lisina E., Okhotin D.J., Nouraie M., Nekhai S., Ammosova T., Niu X.M., Prchal J.T., Zhang X., Gordeuk V.R. Prospective study of thrombosis and thrombospondin-1 expression in Chuvash polycythemia. Haematologica. 2017;102(5): e166–9. doi: 10.3324/haematol.2016.158170.
12. Bushuev V.I., Miasnikova G.Y., Sergueeva A.I., Polyakova L.A., Okhotin D., Gaskin P.R., Debebe Z., Nekhai S., Castro O.L., Prchal J.T., Gordeuk V.R. Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia. Haematologica. 2006;91(6):744–9. PMID: 16769575.
13. Gordeuk V.R., Miasnikova G.Y., Sergueeva A.I., Niu X., Nouraie M., Okhotin D.J., Polyakova L.A., Ammosova T., Nekhai S., Ganz T., Prchal J.T. Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression. Blood. 2011;118(19):5278–82. doi: 10.1182/blood-2011-03-345512.
14. Shah B.N., Zhang X., Sergueeva A.I., Miasnikova G.Y., Ganz T., Prchal J.T., Gordeuk V.R. Increased transferrin protects from thrombosis in Chuvash erythrocytosis. Am J Hematol. 2023;98(10):1532–9. doi: 10.1002/ajh.27021.
15. Niu X., Miasnikova G.Y., Sergueeva A.I., Polyakova L.A., Okhotin D.J., Tuktanov N.V., Nouraie M., Ammosova T., Nekhai S., Gordeuk V.R. Altered cytokine profi les in patients with Chuvash polycythemia. Am J Hematol. 2009;84(2):74–8. doi: 10.1002/ajh.21327.
16. Gordeuk V.R., Sergueeva A.I., Miasnikova G.Y., Okhotin D., Voloshin Y., Choyke P.L., Butman J.A., Jedlickova K., Prchal J.T., Polyakova L.A. Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood. 2004;103(10):3924–32. doi: 10.1182/blood-2003-07-2535.
17. Sergueeva A.I., Miasnikova G.Y., Okhotin D.J., Levina A.A., Debebe Z., Ammosova T., Niu X., Romanova E.A., Nekhai S., DiBello P.M., Jacobsen D.W., Prchal J.T., Gordeuk V.R. Elevated homocysteine, glutathione and cysteinylglycine concentrations in patients homozygous for the Chuvash polycythemia VHL mutation. Haematologica. 2008;93(2):279–82. doi: 10.3324/haematol.11851.
18. Negro A., Graiani G., Nicoli D., Farnetti E., Casali B., Verzicco I., Tedeschi S., Ghirarduzzi A., Cannone V., Marco L.D.E., Filice A., Gemelli G., Giunta A., Cabassi A. Concurrent heterozygous Von-Hippel–Lindau and transmembrane-protein-127 gene mutation causing an erythropoietin-secreting pheochromocytoma in a normotensive patient with severe erythrocytosis. J Hypertens. 2020;38(2):340–6. doi: 10.1097/HJH.0000000000002253.
19. Lanikova L., Lorenzo F., Yang C., Vankayalapati H., Drachtman R., Divoky V., Prchal J.T. Novel homozygous VHL mutation in exon 2 is associated with congenital polycythemia but not with cancer. Blood. 2013;121(19):3918–24. doi: 10.1182/blood-2012-11-469296.
20. Woodward E.R., Wall K., Forsyth J., Macdonald F., Maher E.R. VHL mutation analysis in patients with isolated central nervous system haemangioblastoma. Brain. 2007;130(Pt 3):836–42. doi: 10.1093/brain/awl362.
21. Dunham-Snary K.J., Wu D., Sykes E.A., Thakrar A., Parlow L.R.G., Mewburn J.D., Parlow J.L., Archer S.L. Hypoxic Pulmonary Vasoconstriction. Chest. 2017;151(1):181–92. doi: 10.1016/j.chest.2016.09.001.
22. Sable C.A., Aliyu Z.Y., Dham N., Nouraie M., Sachdev V., Sidenko S., Miasnikova G.Y., Polyakova L.A., Sergueeva A.I., Okhotin D.J., Bushuev V., Remaley A.T., Niu X., Castro O.L., Gladwin M.T., Kato G.J., Prchal J.T., Gordeuk V.R. Pulmonary artery pressure and iron defi ciency in patients with upregulation of hypoxia sensing due to homozygous VHLR200W mutation (Chuvash polycythemia). Haematologica. 2012;97(2):193–200. doi: 10.3324/haematol.2011.051839.
23. Zhang X., Zhang W., Ma S.-F., Desai A.A., Saraf S., Miasniakova G., Sergueeva A., Ammosova T., Xu M., Nekhai S., Abbasi T., Casanova N.G., Steinberg M.H., Baldwin C.T., Sebastiani P., Prchal J.T., Kittles R., Garcia J.G.N., Machado R.F., Gordeuk V.R. Hypoxic Response Contributes to Altered Gene Expression and Precapillary Pulmonary Hypertension in Patients With Sickle Cell Disease. Circulation. 2014;129(16):1650–8. doi: 10.1161/CIRCULATIONAHA.113.005296.
24. Miasnikova G.Y., Sergueeva A.I., Nouraie M., Niu X., Okhotin D.J., Polyakova L.A., Ganz T., Prchal J.T., Gordeuk V.R. The heterozygote advantage of the Chuvash polycythemia VHLR200W mutation may be protection against anemia. Haematologica. 2011;96(9):1371–4. doi: 10.3324/haematol.2011.045609.
25. Zhang X., Zhang W., Ma S.-F., Miasniakova G., Sergueeva A., Ammosova T., Xu M., Nekhai S., Nourai M., Wade M.S., Prchal J.T., Garcia J.G.N., Machado R.F., Gordeuk V.R. Iron defi ciency modifi es gene expression variation induced by augmented hypoxia sensing. Blood Cells Mol Dis. 2014;52(1):35–45. doi: 10.1016/j.bcmd.2013.07.016.
26. McClain D.A., Abuelgasim K.A., Nouraie M., Salomon-Andonie J., Niu X., Miasnikova G., Polyakova L.A., Sergueeva A., Okhotin D.J., Cherqaoui R., Okhotin D., Cox J.E., Swierczek S., Song J., Simon M.C., Huang J., Simcox J.A., Yoon D., Prchal J.T., Gordeuk V.R. Decreased serum glucose and glycosylated hemoglobin levels in patients with Chuvash polycythemia: a role for HIF in glucose metabolism. J Mol Med. 2013;91(1):59–67. doi: 10.1007/s00109-012-0961-5.
27. Perrotta S., Roberti D., Bencivenga D., Corsetto P., O’Brien K.A., Caiazza M., Stampone E., Allison L., Fleck R.A., Scianguetta S., Tartaglione I., Robbins P.A., Casale M., West J.A., FranziniArmstrong C., Griffi n J.L., Rizzo A.M., Sinisi A.A., Murray A.J., Borriello A., Formenti F., Della Ragione F. Eff ects of Germline VHL Defi ciency on Growth, Metabolism, and Mitochondria. N Engl J Med. 2020;382(9):835–44. doi: 10.1056/NEJMoa1907362.
28. Formenti F., Constantin-Teodosiu D., Emmanuel Y., Cheeseman J., Dorrington K.L., Edwards L.M., Humphreys S.M., Lappin T.R.J., McMullin M.F., McNamara C.J., Mills W., Murphy J.A., O’Connor D.F., Percy M.J., Ratcliff e P.J., Smith T.G., Treacy M., Frayn K.N., Greenhaff P.L., Karpe F., Clarke K., Robbins P.A. Regulation of human metabolism by hypoxia-inducible factor. Proc Natl Acad Sci U S A. 2010;107(28):12722–7. doi: 10.1073/pnas.1002339107.
29. Zhang X., Zhang W., Saraf S.L., Nouraie M., Han J., Gowhari M., Hassan J., Miasnikova G., Sergueeva A., Nekhai S., Kittles R., Machado R.F., Garcia J.G.N., Gladwin M.T., Steinberg M.H., Sebastiani P., McClain D.A., Gordeuk V.R. Genetic polymorphism of APOB is associated with diabetes mellitus in sickle cell disease. Hum Genet. 2015;134(8):895–904. doi: 10.1007/s00439-015-1572-3.
30. Yoon D., Okhotin D.V., Kim B., Okhotina Y., Okhotin D.J., Miasnikova G.Y., Sergueeva A.I., Polyakova L.A., Maslow A., Lee Y., Semenza G.L., Prchal J.T., Gordeuk V.R. Increased size of solid organs in patients with Chuvash polycythemia and in mice with altered expression of HIF-1α and HIF-2α. J Mol Med. 2010;88(5):523–30. doi: 10.1007/s00109-010-0599-0.
31. Zhou A.W., Knoche E.M., Engle E.K., Ban-Hoefen M., Kaiwar C., Oh S.T. Clinical Improvement with JAK2 Inhibition in Chuvash Polycythemia. N Engl J Med. 2016;375(5):494–6. doi: 10.1056/NEJMc1600337.
32. Russell R.C., Sufan R.I., Zhou B., Heir P., Bunda S., Sybingco S.S., Greer S.N., Roche O., Heathcote S.A., Chow V.W.K., Boba L.M., Richmond T.D., Hickey M.M., Barber D.L., Cheresh D.A., Simon M.C., Irwin M.S., Kim W.Y., Ohh M. Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia. Nat Med. 2011;17(7):845–53. doi: 10.1038/nm.2370.
33. Gordeuk V., Prchal J. Vascular Complications in Chuvash Polycythemia. Semin Thromb Hemost. 2006;32(3):289–94. doi: 10.1055/s-2006-939441.
Review
For citations:
Sergeev I.I., Burtsev K.D., Smetanina N.S. Hereditary erythrocytosis in the Chuvash Republic. À literature review. Russian Journal of Pediatric Hematology and Oncology. 2024;11(2):74-84. (In Russ.) https://doi.org/10.21682/2311-1267-2024-11-2-74-84
Views:
192
Email this article 